What is Natural Cycles?
Founded in 2013, Natural Cycles operates at the intersection of reproductive health and data science. The company provides a certified digital contraceptive method that utilizes a thermometer and a sophisticated algorithm to identify fertile and non-fertile days. By positioning itself as a natural, hormone-free alternative to traditional birth control, Natural Cycles has carved out a distinct market niche, appealing to health-conscious consumers who prioritize data-driven wellness. The firm's market position is bolstered by its status as a regulated medical device, distinguishing it from generic wellness applications and establishing a high barrier to entry for competitors.
How much funding has Natural Cycles raised?
Natural Cycles has raised a total of $99.5M across 5 funding rounds:
Other Financing Round
$1.5M
Series A
$6M
Series B
$30M
Unspecified
$7M
Series C
$55M
Other Financing Round (2015): $1.5M with participation from e.ventures and Sunstone Capital
Series A (2016): $6M led by E-ventures, Bonnier Media Growth, and Sunstone Capital
Series B (2017): $30M supported by Bonnier Growth Media, EQT Ventures, Sunstone Capital, and E-ventures
Unspecified (2023): $7M featuring Bonnier Ventures, Headline, EQT Ventures, Heartcore Capital, and Samsung Ventures
Series C (2024): $55M backed by Lauxera Capital Partners and Point72 Ventures
Key Investors in Natural Cycles
Lauxera Capital Partners
Lauxera Capital Partners is an independent, international investment fund that focuses on growth companies in the Healthtech sector, partnering with founders to enhance efficiency and reduce costs.
Point72 Ventures
Point72 Ventures is a venture capital firm specializing in early-stage investments across financial technology and enterprise software, utilizing a practitioner-first philosophy to drive operational value.
Bonnier Growth Media
Bonnier Capital is the investment division of the Bonnier Group, focusing on promising companies in structurally growing industries and providing long-term management support.
What's next for Natural Cycles?
With the recent influx of capital, Natural Cycles is well-positioned to accelerate its international expansion and deepen its investment in R&D. The strategic focus will likely shift toward enhancing the user experience through advanced predictive analytics and expanding its footprint in key global markets. As the company matures, the integration of its technology into broader healthcare ecosystems remains a primary objective, potentially opening new avenues for partnerships with clinical providers and insurance platforms. The firm's ability to maintain its regulatory edge while scaling its user base will be the critical determinant of its long-term success in the evolving digital health landscape.
See full Natural Cycles company page
